ReviewEmerging infectious diseases
Guarding against the most dangerous emerging pathogens.
Review in Emerging infectious diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- The uneasy coexistence of predators and pathogens.The European physical journal. E, Soft matter · 2020Article
- EMERGING INFECTIOUS DISEASES - OVERVIEW.Disease-a-month : DM · 2018Review
- Complexity and biosemiotics in evolutionary ecology of zoonotic infectious agents.Evolutionary applications · 2018Article
- The Homolog of the GeneInfection and immunity · 2018Article
- Article
- Evidence for positive selection and recombination hotspots in Deformed wing virus (DWV).Scientific reports · 2017Article
- Benign Rabbit Caliciviruses Exhibit Evolutionary Dynamics Similar to Those of Their Virulent Relatives.Journal of virology · 2016Article
- Global infectious diseases - the new norm for the United States?Disease-a-month : DM · 2013Article
- Pathogen-host-environment interplay and disease emergence.Emerging microbes & infections · 2013Review
- Insights from genomic comparisons of genetically monomorphic bacterial pathogens.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2012Review
- Global infections--avian influenza and other significant emerging pathogens: an overview.Disease-a-month : DM · 2007Review
- Pathogen survival in the external environment and the evolution of virulence.Biological reviews of the Cambridge Philosophical Society · 2004Review
- Characterization of grvA, an antivirulence gene on the gifsy-2 phage in Salmonella enterica serovar typhimurium.Journal of bacteriology · 2001Article
- Virulence evolution in a virus obeys a trade-off.Proceedings. Biological sciences · 1999Article
- The evolution of virulence and emerging diseases.Journal of urban health : bulletin of the New York Academy of Medicine · 1998Article
- Foodborne illness: implications for the future.Emerging infectious diseasesReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Control of emerging infectious diseases will be difficult because of the large number of disease-causing organisms that are emerging or could emerge and the great diversity of geographic areas in which emergence can occur. The modern view of the evolution of pathogen virulence--specifically its focus on the tradeoff between costs and benefits to the pathogen from increased host exploitation--allows control programs to identify and focus on the most dangerous pathogens (those that can be established with high virulence in human populations).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.